Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults

Clinical trial NCT06846567 · COMPLETED

Trial details

NCT number: NCT06846567
Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Neuropathies Diabetes Mellitus

Start date: 2024-12-01
Primary completion: 2025-01-04
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.